Arblet

Arblet Inc., established in September 2016, is a Tokyo-based company operating in the health-tech sector. The firm was co-founded by Kosuke Shimizu, who serves as CEO, and Takatoshi Tashiro, the company's COO. Arblet is focused on the development of non-invasive wearable devices and accompanying cloud-based analysis tools to monitor internal physiological changes.

The company's core product is a wrist-worn device that provides continuous measurement of various biological data points. Key features include cuff-less blood pressure monitoring, pulse rate, body temperature, and respiration rate tracking. This technology aims to identify shifts in a user's health status by cross-analyzing behavioral and vital data. The system is designed to provide users with a non-invasive method for understanding their bodily changes and to deliver insights that could indicate future disease risks or trigger emergency alerts for individuals with or without existing health concerns.

Arblet operates on a B2B model, targeting the digital health, wearables, and quantified self markets within the broader healthcare technology industry. The business generates revenue from its venture capital-backed operations, having completed an Early Stage VC funding round in January 2019. Its investor portfolio includes both corporations and venture capital firms such as Macnica, Monozukuri Ventures, FGN ABBA Lab, Colopl Next, and SG Incubate.

Keywords: health-tech, wearable devices, non-invasive monitoring, vital signs tracking, cuff-less blood pressure, cloud health analysis, digital health, medical devices, preventative healthcare, biometric data, remote patient monitoring, quantified self, physiological monitoring, chronic disease management, telehealth, biotechnology, corporate wellness, health data analytics, Japanese startup, Kosuke Shimizu